Consumer Defensive
Live Price
Offline$39.62
-1.81% today
1Y Change
-5.19%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Koninklijke Ahold Delhaize N.V. (ADRNY) is a Consumer Defensive stock with a market cap of $34.60B and listed on OTC. The stock last traded around $39.62 and down 5.2% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +3.4%, EPS growth of +26.8%, a dividend yield of 3.2%. What stands out right now is revenue +3.4%, EPS +26.8%, free cash flow +78.1% with operating margin 3.8% and ROIC 8.6%. The dividend matters to the case here, with a current yield around 3.2%. Valuation is more restrained than many high-expectation growth names at P/E 15.4 and price/sales 0.4. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines ADRNY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ADRNY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ADRNY Max Drawdown
-20.46%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ADRNY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$75.6B
-13.1% YoY
FY Net Income
$2.2B
-11.8% YoY
Free Cash Flow
$3.1B
-14.4% YoY
Revenue Growth
+3.4%
EPS Growth
+26.8%
Gross Margin
26.5%
Net Margin
2.4%
Income statement
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 92.4B | 89.4B | 88.7B | 87.0B | 75.6B |
| Gross Profit | 24.5B | 23.8B | 23.9B | 23.3B | 20.7B |
| Operating Income | 3.1B | 2.8B | 2.8B | 3.8B | 3.3B |
| EBITDA | 6.6B | 6.5B | 6.5B | 7.3B | 6.3B |
| Net Income | 2.3B | 1.8B | 1.9B | 2.5B | 2.2B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.5B | 6.2B | 3.5B | 3.2B | 3.1B |
| Total Assets | 49.1B | 51.8B | 47.8B | 48.6B | 45.7B |
| Total Liabilities | 34.9B | 36.4B | 33.1B | 33.1B | 32.0B |
| Shareholder Equity | 14.2B | 15.5B | 14.8B | 15.4B | 13.7B |
| Total Debt | 18.4B | 20.3B | 17.8B | 17.7B | 17.1B |
| Net Debt | 14.9B | 14.2B | 14.3B | 14.5B | 14.0B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
5.5B
-10.5% YoY
Capital Expenditures
2.4B
+4.8% YoY
Free Cash Flow
3.1B
-14.4% YoY
Key ratios
Gross Margin
26.5%
Operating Margin
3.8%
Net Margin
2.4%
ROE
15.7%
Debt / Equity
0.32x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.